$2.32-0.41 (-15.02%)
News25/Ratings0
Price$2.32+0.00 (+0.00%)
2026-01-162026-04-22
News · 26 weeks14+150%
2025-10-262026-04-19
Mix790d
- SEC Filings3(43%)
- Insider2(29%)
- Leadership1(14%)
- Other1(14%)
Latest news
25 items- SECSEC Form SCHEDULE 13D filed by Longevity Health Holdings Inc.SCHEDULE 13D - Longevity Health Holdings, Inc. (0001842939) (Subject)
- INSIDERSEC Form 4 filed by Ajjarapu J. Ram4 - Longevity Health Holdings, Inc. (0001842939) (Issuer)
- INSIDERSEC Form 3 filed by new insider Ajjarapu J. Ram3 - Longevity Health Holdings, Inc. (0001842939) (Issuer)
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form 10-K filed by Longevity Health Holdings Inc.10-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECLongevity Health Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- PRLongevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused GrowthPITTSBURGH, March 17, 2026 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (OTCQB:XAGE) ("Longevity" or the "Company") announced that its Board of Directors has appointed Ram Ajjarapu as Chairman and Chief Executive Officer, effective as of March 16, 2026. "Ram brings a strong track record of scaling businesses and executing value-creating transactions," said Rajiv Shukla, outgoing Chairman and Chief Executive Officer. "We look forward to his leadership as Longevity seeks to advance its growth strategy through acquisitions as a public company." "I am excited to join Longevity and help build the Company's acquisition platform," said Mr. Ajjarapu. "My investment and leadership commitme
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECLongevity Health Holdings Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form 25-NSE filed by Longevity Health Holdings Inc.25-NSE - Longevity Health Holdings, Inc. (0001842939) (Subject)
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form 10-Q filed by Longevity Health Holdings Inc.10-Q - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECLongevity Health Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form RW filed by Longevity Health Holdings Inc.RW - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECLongevity Health Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form 10-Q filed by Longevity Health Holdings Inc.10-Q - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECLongevity Health Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Changes in Control of Registrant, Other Events, Financial Statements and Exhibits8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- PRLongevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs TransactionPITTSBURGH, July 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (NASDAQ:XAGE), a company focused on human longevity and healthy aging ("Longevity", the "Company", "we", "our", or "us"), today announced the execution of a definitive merger agreement (the "Merger") with True Health Inc., a leading player in the fast growing plasma collection industry under the THPlasma brand ("THPlasma"), to combine the companies in an all-stock transaction. Following the closing of the Merger (the "Closing"), the combined company is expected to continue to trade on Nasdaq under the symbol "XAGE." Longevity today also announced the mutual termination of the 20/20 BioLabs transaction purs
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECLongevity Health Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECAmendment: SEC Form 10-K/A filed by Longevity Health Holdings Inc.10-K/A - Longevity Health Holdings, Inc. (0001842939) (Filer)